# HF Foods Group Inc.: financial statements, quarterly

HFFG · Nasdaq · CIK 1680873 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hffg.md) · [Financials](/companies/hffg/financials.md) · [Filings](/companies/hffg/filings.md) · [Insiders](/companies/hffg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hffg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [281](/filings/0001680873-24-000065.md) | [281 d](/filings/0001680873-25-000006.md) | [296](/filings/0001680873-25-000036.md) | [302](/filings/0001628280-25-039583.md) | [298](/filings/0001680873-25-000074.md) | [305 d](/filings/0001680873-26-000015.md) | [298](/filings/0001680873-26-000027.md) | [315](/filings/0001680873-26-000060.md) | [307](/filings/0001680873-25-000074.md) | [308 d](/filings/0001680873-26-000015.md) | [312](/filings/0001680873-26-000027.md) | [324](/filings/0001680873-26-000060.md) |
| Cost of revenue | $m | [231](/filings/0001680873-24-000065.md) | [229 d](/filings/0001680873-25-000006.md) | [245](/filings/0001680873-25-000036.md) | [250](/filings/0001628280-25-039583.md) | [248](/filings/0001680873-25-000074.md) | [253 d](/filings/0001680873-26-000015.md) | [247](/filings/0001680873-26-000027.md) | [260](/filings/0001680873-26-000060.md) | [257](/filings/0001680873-25-000074.md) | [257 d](/filings/0001680873-26-000015.md) | [261](/filings/0001680873-26-000027.md) | [269](/filings/0001680873-26-000060.md) |
| Gross profit | $m | [50.9](/filings/0001680873-24-000065.md) | [52.3 d](/filings/0001680873-25-000006.md) | [50.4](/filings/0001680873-25-000036.md) | [52.5](/filings/0001628280-25-039583.md) | [50.2](/filings/0001680873-25-000074.md) | [52.2 d](/filings/0001680873-26-000015.md) | [51.0](/filings/0001680873-26-000027.md) | [55.1](/filings/0001680873-26-000060.md) | [50.4](/filings/0001680873-25-000074.md) | [51.1 d](/filings/0001680873-26-000015.md) | [50.5](/filings/0001680873-26-000027.md) | [55.0](/filings/0001680873-26-000060.md) |
| Selling, general and administrative | $m | [48.8](/filings/0001680873-24-000065.md) | [41.0 d](/filings/0001680873-25-000006.md) | [50.5](/filings/0001680873-25-000036.md) | [49.8](/filings/0001628280-25-039583.md) | [49.7](/filings/0001680873-25-000074.md) | [48.0 d](/filings/0001680873-26-000015.md) | [49.8](/filings/0001680873-26-000027.md) | [51.0](/filings/0001680873-26-000060.md) | [49.3](/filings/0001680873-25-000074.md) | [51.7 d](/filings/0001680873-26-000015.md) | [49.5](/filings/0001680873-26-000027.md) | [52.2](/filings/0001680873-26-000060.md) |
| Operating income | $m | [2.1](/filings/0001680873-24-000065.md) | [11.2 d](/filings/0001680873-25-000006.md) | [(0.1)](/filings/0001680873-25-000036.md) | [2.6](/filings/0001628280-25-039583.md) | [0.5](/filings/0001680873-25-000074.md) | [(42.2) d](/filings/0001680873-26-000015.md) | [1.2](/filings/0001680873-26-000027.md) | [4.1](/filings/0001680873-26-000060.md) | [1.1](/filings/0001680873-25-000074.md) | [(39.4) d](/filings/0001680873-26-000015.md) | [1.0](/filings/0001680873-26-000027.md) | [2.8](/filings/0001680873-26-000060.md) |
| Interest expense | $m | [2.7](/filings/0001628280-23-038280.md) | [3.0 d](/filings/0001680873-24-000010.md) | [2.8](/filings/0001680873-24-000029.md) | [3.1](/filings/0001628280-25-039583.md) | [2.6](/filings/0001680873-25-000074.md) | [2.8 d](/filings/0001680873-26-000015.md) | [2.6](/filings/0001680873-26-000027.md) | [2.8](/filings/0001680873-26-000060.md) | [2.9](/filings/0001680873-25-000074.md) | [3.1 d](/filings/0001680873-26-000015.md) | [2.8](/filings/0001680873-26-000027.md) | [2.9](/filings/0001680873-26-000060.md) |
| Income tax | $m | [(0.0)](/filings/0001680873-24-000065.md) | [2.1 d](/filings/0001680873-25-000006.md) | [(0.2)](/filings/0001680873-25-000036.md) | [1.6](/filings/0001628280-25-039583.md) | [(1.3)](/filings/0001680873-25-000074.md) | [1.8 d](/filings/0001680873-26-000015.md) | [(0.9)](/filings/0001680873-26-000027.md) | [0.5](/filings/0001680873-26-000060.md) | [(0.8)](/filings/0001680873-25-000074.md) | [(4.8) d](/filings/0001680873-26-000015.md) | [(0.4)](/filings/0001680873-26-000027.md) | [0.2](/filings/0001680873-26-000060.md) |
| Net income | $m | [1.9](/filings/0001680873-24-000065.md) | [2.7 d](/filings/0001680873-25-000006.md) | [(0.7)](/filings/0001680873-25-000036.md) | [0.0](/filings/0001628280-25-039583.md) | [(3.9)](/filings/0001680873-25-000074.md) | [(43.9) d](/filings/0001680873-26-000015.md) | [(1.6)](/filings/0001680873-26-000027.md) | [1.2](/filings/0001680873-26-000060.md) | [(1.1)](/filings/0001680873-25-000074.md) | [(37.3) d](/filings/0001680873-26-000015.md) | [1.2](/filings/0001680873-26-000027.md) | [2.6](/filings/0001680873-26-000060.md) |
| Diluted EPS | $ per share | [0.03](/filings/0001680873-24-000065.md) | not reported | [(0.01)](/filings/0001680873-25-000036.md) | [0.00](/filings/0001628280-25-039583.md) | [(0.07)](/filings/0001680873-25-000074.md) | not reported | [(0.03)](/filings/0001680873-26-000027.md) | [0.02](/filings/0001680873-26-000060.md) | [(0.02)](/filings/0001680873-25-000074.md) | not reported | [0.02](/filings/0001680873-26-000027.md) | [0.05](/filings/0001680873-26-000060.md) |
| Basic EPS | $ per share | [0.03](/filings/0001680873-24-000065.md) | not reported | [(0.01)](/filings/0001680873-25-000036.md) | [0.00](/filings/0001628280-25-039583.md) | [(0.07)](/filings/0001680873-25-000074.md) | not reported | [(0.03)](/filings/0001680873-26-000027.md) | [0.02](/filings/0001680873-26-000060.md) | [(0.02)](/filings/0001680873-25-000074.md) | not reported | [0.02](/filings/0001680873-26-000027.md) | [0.05](/filings/0001680873-26-000060.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [14.3](/filings/0001628280-23-038280.md) | [15.2](/filings/0001680873-25-000006.md) | [18.2](/filings/0001680873-24-000029.md) | [14.0](/filings/0001680873-24-000058.md) | [11.4](/filings/0001680873-24-000065.md) | [14.5](/filings/0001680873-26-000015.md) | [16.1](/filings/0001680873-25-000036.md) | [15.7](/filings/0001628280-25-039583.md) | [12.3](/filings/0001680873-25-000074.md) | [8.6](/filings/0001680873-26-000060.md) | [11.1](/filings/0001680873-26-000027.md) | [18.1](/filings/0001680873-26-000060.md) |
| Current assets | $m | [197](/filings/0001628280-23-038280.md) | [179](/filings/0001680873-25-000006.md) | [185](/filings/0001680873-24-000029.md) | [194](/filings/0001680873-24-000058.md) | [193](/filings/0001680873-24-000065.md) | [178](/filings/0001680873-26-000015.md) | [188](/filings/0001680873-25-000036.md) | [202](/filings/0001628280-25-039583.md) | [208](/filings/0001680873-25-000074.md) | [194](/filings/0001680873-26-000060.md) | [192](/filings/0001680873-26-000027.md) | [205](/filings/0001680873-26-000060.md) |
| Total assets | $m | [623](/filings/0001628280-23-038280.md) | [597](/filings/0001680873-25-000006.md) | [603](/filings/0001680873-24-000029.md) | [617](/filings/0001680873-24-000058.md) | [613](/filings/0001680873-24-000065.md) | [550](/filings/0001680873-26-000015.md) | [582](/filings/0001680873-25-000036.md) | [594](/filings/0001628280-25-039583.md) | [595](/filings/0001680873-25-000074.md) | [542](/filings/0001680873-26-000060.md) | [546](/filings/0001680873-26-000027.md) | [557](/filings/0001680873-26-000060.md) |
| Current liabilities | $m | [162](/filings/0001628280-23-038280.md) | [143](/filings/0001680873-25-000006.md) | [151](/filings/0001680873-24-000029.md) | [164](/filings/0001680873-24-000058.md) | [163](/filings/0001680873-24-000065.md) | [145](/filings/0001680873-26-000015.md) | [158](/filings/0001680873-25-000036.md) | [170](/filings/0001628280-25-039583.md) | [175](/filings/0001680873-25-000074.md) | [165](/filings/0001680873-26-000060.md) | [172](/filings/0001680873-26-000027.md) | [184](/filings/0001680873-26-000060.md) |
| Total liabilities | $m | [330](/filings/0001628280-23-038280.md) | [309](/filings/0001680873-25-000006.md) | [315](/filings/0001680873-24-000029.md) | [328](/filings/0001680873-24-000058.md) | [327](/filings/0001680873-24-000065.md) | [309](/filings/0001680873-26-000015.md) | [342](/filings/0001680873-25-000036.md) | [352](/filings/0001628280-25-039583.md) | [354](/filings/0001680873-25-000074.md) | [338](/filings/0001680873-26-000060.md) | [341](/filings/0001680873-26-000027.md) | [349](/filings/0001680873-26-000060.md) |
| Long-term debt | $m | [111](/filings/0001628280-23-038280.md) | [109](/filings/0001680873-25-000006.md) | [107](/filings/0001680873-24-000029.md) | [106](/filings/0001680873-24-000058.md) | [105](/filings/0001680873-24-000065.md) | [103](/filings/0001680873-26-000015.md) | [102](/filings/0001680873-25-000036.md) | [101](/filings/0001628280-25-039583.md) | [100](/filings/0001680873-25-000074.md) | [99.4](/filings/0001680873-26-000060.md) | [95.6](/filings/0001680873-26-000027.md) | [95.3](/filings/0001680873-26-000060.md) |
| Current portion of debt | $m | [5.9](/filings/0001628280-23-038280.md) | [5.5](/filings/0001680873-25-000006.md) | [5.4](/filings/0001680873-24-000029.md) | [5.4](/filings/0001680873-24-000058.md) | [5.4](/filings/0001680873-24-000065.md) | [5.4](/filings/0001680873-26-000015.md) | [5.4](/filings/0001680873-25-000036.md) | [5.4](/filings/0001628280-25-039583.md) | [7.0](/filings/0001680873-25-000074.md) | [6.7](/filings/0001680873-26-000060.md) | [5.1](/filings/0001680873-26-000027.md) | [5.2](/filings/0001680873-26-000060.md) |
| Shareholders' equity | $m | [289](/filings/0001628280-23-038280.md) | [287](/filings/0001680873-25-000006.md) | [287](/filings/0001680873-24-000029.md) | [286](/filings/0001680873-24-000058.md) | [283](/filings/0001680873-24-000065.md) | [239](/filings/0001680873-26-000015.md) | [238](/filings/0001680873-25-000036.md) | [240](/filings/0001628280-25-039583.md) | [239](/filings/0001680873-25-000074.md) | [202](/filings/0001680873-26-000060.md) | [204](/filings/0001680873-26-000027.md) | [207](/filings/0001680873-26-000060.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [11.9 d](/filings/0001680873-24-000065.md) | [(22.3) d](/filings/0001680873-25-000006.md) | [11.2](/filings/0001680873-25-000036.md) | [(9.3) d](/filings/0001628280-25-039583.md) | [2.3 d](/filings/0001680873-25-000074.md) | [18.4 d](/filings/0001680873-26-000015.md) | [6.9](/filings/0001680873-26-000027.md) | [3.5 d](/filings/0001680873-26-000060.md) | [(6.0) d](/filings/0001680873-25-000074.md) | [21.0 d](/filings/0001680873-26-000015.md) | [15.3](/filings/0001680873-26-000027.md) | [(1.3) d](/filings/0001680873-26-000060.md) |
| Capital expenditure | $m | [2.0 d](/filings/0001680873-24-000065.md) | [0.0 d](/filings/0001680873-25-000006.md) | [2.6](/filings/0001680873-25-000036.md) | [3.7 d](/filings/0001628280-25-039583.md) | [3.1 d](/filings/0001680873-25-000074.md) | [3.1 d](/filings/0001680873-26-000015.md) | [3.6](/filings/0001680873-26-000027.md) | [3.2 d](/filings/0001680873-26-000060.md) | [3.3 d](/filings/0001680873-25-000074.md) | [8.9 d](/filings/0001680873-26-000015.md) | [15.3](/filings/0001680873-26-000027.md) | [5.0 d](/filings/0001680873-26-000060.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q2 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [53.8](/filings/0001628280-23-038280.md) | [53.8](/filings/0001680873-24-000029.md) | [54.0](/filings/0001680873-24-000058.md) | [54.5](/filings/0001680873-24-000065.md) | [52.2](/filings/0001680873-25-000036.md) | [52.7](/filings/0001628280-25-039583.md) | [52.7](/filings/0001680873-25-000074.md) | [52.7](/filings/0001680873-26-000027.md) | [53.4](/filings/0001680873-26-000060.md) | [53.0](/filings/0001680873-25-000074.md) | [53.9](/filings/0001680873-26-000027.md) | [53.9](/filings/0001680873-26-000060.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 53,900,945 at 2026-08-05, from the cover of the [10-Q filed 2026-08-10](/filings/0001680873-26-000060.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.